XML 27 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Other Assets
 3 Months Ended
Mar. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other Assets

NOTE 9 – OTHER ASSETS

 

On April 9, 2020, pursuant to a licensing agreement entered into in March 2020, the Company received 10-year warrants to purchase 127,000 shares of Sanuwave Health, Inc. at a price of $0.19 per share. The fair value for warrants received is estimated at the date of grant using a Black-Scholes-Merton pricing model with the following underlying assumptions:

 

Price at valuation   $ 0.17  
Exercise price   $ 0.19  
Risk free interest     1.74 %
Expected term (in years)     9  
Volatility     139.2 %

 

The Company considers this to be level 3 inputs and is valued at each reporting period. The fair value of these warrants decreased by $2 during the quarter, leaving a balance of $21 as of March 31, 2021.